Chronic dermatomycoses of the foot as risk factors for acute bacterial cellulitis of the leg: A case-control study

被引:130
作者
Roujeau, JC [1 ]
Sigurgeirsson, B
Korting, HC
Kerl, H
Paul, C
机构
[1] Hop Henri Mondor, Serv Dermatol, FR-940100 Creteil, France
[2] Hop E Mueller, Serv Dermatol, Mulhouse, France
[3] Landspitali Univ Hosp, Reykjavik, Iceland
[4] Univ Munich, Dermatol Clin, Munich, Germany
[5] Univ Munich, Outpatients Clin, Munich, Germany
[6] Univ Clin, Dept Dermatol & Venereol, Graz, Austria
[7] Novartis Pharma AG, Clin Res, Basel, Switzerland
关键词
tinea pedis; onychomycosis; foot dermatomycosis; bacterial cellulitis; risk factors;
D O I
10.1159/000080853
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Objective: To assess the role of foot dermatomycosis ( tinea pedis and onychomycosis) and other candidate risk factors in the development of acute bacterial cellulitis of the leg. Methods: A case-control study, including 243 patients ( cases) with acute bacterial cellulitis of the leg and 467 controls, 2 per case, individually matched for gender, age (+/-5 years), hospital and admission date (+/-2 months). Results: Overall, mycology-proven foot dermatomycosis was a significant risk factor for acute bacterial cellulitis (odds ratio, OR: 2.4; p < 0.001), as were tinea pedis interdigitalis (OR: 3.2; p < 0.001), tinea pedis plantaris (OR: 1.7; p = 0.005) and onychomycosis (OR: 2.2; p < 0.001) individually. Other risk factors included: disruption of the cutaneous barrier, history of bacterial cellulitis, chronic venous insufficiency and leg oedema. Conclusions: Tinea pedis and onychomycosis were found to be significant risk factors for acute bacterial cellulitis of the leg that are readily amenable to treatment with effective pharmacological therapy. Copyright (C) 2004 S. Karger AG, Basel.
引用
收藏
页码:301 / 307
页数:7
相关论文
共 13 条
[1]  
[Anonymous], PRACT GUID ID EV TRE
[2]  
BRESLOW NE, 1980, INT AGENCY RES CANC, V1
[3]   Risk factors for erysipelas of the leg (cellulitis): case-control study [J].
Dupuy, A ;
Benchikhi, H ;
Roujeau, JC ;
Bernard, P ;
Vaillant, L ;
Chosidov, O ;
Sassolas, B ;
Guillaume, JC ;
Grob, JJ ;
Bastuji-Garin, S .
BRITISH MEDICAL JOURNAL, 1999, 318 (7198) :1591-1594
[4]   Bullous erysipelas: A retrospective study of 26 patients [J].
Guberman, D ;
Gilead, LT ;
Zlotogorski, A ;
Schamroth, J .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1999, 41 (05) :733-737
[5]   Onychomycosis: An evaluation of three sampling methods [J].
Hull, PR ;
Gupta, AK ;
Summerbell, RC .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1998, 39 (06) :1015-1017
[6]   INTERDIGITAL ATHLETES FOOT - INTERACTION OF DERMATOPHYTES AND RESIDENT BACTERIA [J].
LEYDEN, JJ ;
KLIGMAN, AM .
ARCHIVES OF DERMATOLOGY, 1978, 114 (10) :1466-1472
[7]   PREVALENCE OF DERMATOPHYTE ONYCHOMYCOSIS IN THE UNITED-KINGDOM - RESULTS OF AN OMNIBUS SURVEY [J].
ROBERTS, DT .
BRITISH JOURNAL OF DERMATOLOGY, 1992, 126 :23-27
[8]   Erysipelas and tinea pedis [J].
Roldan, YB ;
Mata-Essayag, S ;
Hartung, C .
MYCOSES, 2000, 43 (05) :181-183
[9]   ERYSIPELAS - CHANGING FACES [J].
RONNEN, M ;
SUSTER, S ;
SCHEWACHMILLET, M ;
MODAN, M .
INTERNATIONAL JOURNAL OF DERMATOLOGY, 1985, 24 (03) :169-172
[10]  
SAIS G, 1995, BRIT J DERMATOL, V132, P758, DOI 10.1111/j.1365-2133.1995.tb00722.x